|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hoffmann-La Roche |
|---|---|
| Information provided by: | Hoffmann-La Roche |
| ClinicalTrials.gov Identifier: | NCT00468702 |
Purpose
This study will measure the efficacy and safety of an early postoperative anticoagulation self-management program, using the CoaguChek S device, in patients undergoing mechanical valve replacements. Patients will be randomized into a study group (self-management) or a control group (physician management).
| Condition | Intervention |
|---|---|
|
Cardiovascular Abnormalities |
Device: CoaguChek S |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | Postoperative Canadian Oral Anticoagulation Self-Management (Post-COAGS) Trial |
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | RD-0014, RD000000383-2007 |
| Study First Received: | May 2, 2007 |
| Last Updated: | November 20, 2007 |
| ClinicalTrials.gov Identifier: | NCT00468702 History of Changes |
| Health Authority: | Canada: Health Canada |
|
Cardiovascular Abnormalities Congenital Abnormalities |
|
Cardiovascular Abnormalities Cardiovascular Diseases Congenital Abnormalities |